Notes to SEFA
Title: Governmental Interagency Agreement Activities
Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards includes the Federal assistance activity of BVARI and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
De Minimis Rate Used: N
Rate Explanation: The auditee did not use the de minimis cost rate.
As mentioned in Note 9 to the financial statements, BVARI provides services to the VA Boston Healthcare System under a Memorandum of Understanding (MOU). Funding used under this MOU is provided through Interagency Agreements between the National Institute of Health (NIH), the Department of Defense (DoD) or Food and Drug Administration (FDA) and the Department of Veterans Affairs. BVARI provides support to the VA Precision Medicine Initiative Cohort Program (PMI-CP) for administrative, data management, extraction and storage of specimens, as well as health records and survey data, collected from Veterans who enroll into the Precision Medicine Program. BVARI provides support on the NCI and VAInteragency Group to Accelerate Trials Enrollment (NAVIGATE) program between NIH and the VA. Spending under the PMI-CP MOU amounted toapproximately $4,418,921 for the year ended December 31, 2022. Spending under the PMI-CP (DoD) MOU amounted to approximately $948,337 forthe year ended December 31, 2022. Spending under the NAVIGATE (NIH) MOU amounted to approximately $85,872 for the year ended December 31,2022. Spending under the FDA MOU amounted to approximately $208,436 for the year ended December 31, 2022. Although these funds are sourcedfrom the Federal government, they are not considered expenditures of Federal Grant Awards for the purpose of the Schedule of Expenditures ofFederal Awards and are therefore not included on that schedule.